Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
GLP1ID-TMD-B Individualized Weight Loss * Based on Ivims published study, Ivim patients following the Ivim Protocol lost an average of 46% more weight over 68 weeks when compared to another published clinical GLP-1 trial that included a daily 500-calorie deficit, 150 minutes of weekly exercise, and in-person counseling every four weeks
Guideline Endorsements The 2024 AACE obesity treatment algorithm recommends GLP-1 receptor agonists as first-line pharmacotherapy for patients with BMI of 30 kg/m or above, or 27 kg/m or above with complications [3]
When a craving hits, pause and ask yourself: Am I truly hungry
Common Semaglutide side effects include nausea, vomiting, Diarrhea, constipation, stomach pain, and reduced appetite
